Los Angeles, CA, United States of America

Jesus Manuel Perez Figueroa


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jesus Manuel Perez Figueroa

Introduction

Jesus Manuel Perez Figueroa is a distinguished inventor based in Los Angeles, CA, with a remarkable contribution to the field of theranostic nanoparticles. With two patents to his name, he has made significant strides in advancing therapeutic methods for cancer treatment.

Latest Patents

Figueroa's latest patents showcase groundbreaking advancements in nanoparticle technology. The first patent, titled "Methods and Compositions for Theranostic Nanoparticles," details a nanoparticle designed for drug delivery. This innovative nanoparticle comprises a hyperbranched polyester (HBPE) with a hydrophobic interior, decorated with polyglutamate folate ligands, and incorporates PET detectable isotopes. Additionally, the second patent focuses on "Methods and Compositions for Identifying a Solid Tumor Cell Target." This patent highlights his method for targeted treatment of prostate cancer, revealing compositions that include cancer therapeutic compositions comprising CT20p and nanoparticles conjugated with targeting ligands suitable for solid tumor-specific cell proteins.

Career Highlights

Figueroa's professional journey includes significant roles at renowned research institutions such as the Sanford Burnham Prebys Medical Discovery Institute and Memorial Sloan Kettering Cancer Center. His research efforts at these institutions have contributed to the development of innovative cancer therapies and diagnostic tools.

Collaborations

Throughout his career, Figueroa has worked alongside esteemed colleagues including Annette Khaled and Oscar Santiesteban. Their collaboration has further facilitated research advancements in the field of cancer therapeutics, contributing to innovative approaches to treatment.

Conclusion

Jesus Manuel Perez Figueroa's contributions to the realm of theranostic nanoparticles have established him as a prominent inventor in medical research. His patents not only highlight the potential for targeted cancer treatments but also reflect his dedication to advancing the field of biomedical innovation. With a solid foundation built on collaboration and research, Figueroa continues to inspire and pave the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…